Resumen de First tests of 'youth elixir'
Transfusions of young blood plasma may cut the risk of cancer, Alzheimer's disease and heart disease in older people, according to a controversial new study which required participants to pay for their treatment. Since Aug 2016, Jesse Karmazin's company has been giving people aged 35 to 92 transfusions of blood plasma from people aged between 16 and 25. So far, around 100 people have been treated. The fact that they all paid $8000 to be included, as well as the study's lack of a placebo group, has attracted much criticism.
